Related Experiment Video
Updated: May 12, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell
Kylie Carlson1, Mahmut Kaymakci2, Sebastian E Sattui3
1Medical College of Wisconsin, Milwaukee, WI, USA.
Background:
Patients with polymyalgia rheumatica (PMR) may have subclinical large vessel vasculitis. We compared the incidence of aortic complications in PMR and giant cell arteritis (GCA) to the general population.
Methods:
A retrospective cohort study was performed of patients with PMR and GCA identified by ≥2 ICD-9/ICD-10-CM diagnostic codes and concurrent corticosteroid treatment in the US-based TriNetX database (2000-2024). Matched general population controls were identified (1:3 ratio). The primary outcome, aortic complications, was a composite of aortic aneurysm and dissection/rupture. Adjusted hazard ratios (aHR) were calculated using Cox proportional cause-specific hazard models with PMR as the referent category.
Findings:
Of 57,336 patients, 17,327 had PMR, 4,734 had GCA, and 35,275 were matched controls. Median follow-up time was 3.74 years (interquartile range, 1.8-6.4). The incidence rate of any aortic complication per 1,000 person-years was highest for GCA (11.69), followed by PMR (6.78) and the general population (5.09). Compared to patients with PMR, patients with GCA had a higher risk of any aortic complication (aHR 1.87, 95 % confidence interval (CI) 1.58-2.21); the general population risk was similar (aHR 0.95, 95 % CI 0.84-1.06). In a sensitivity analysis, patients with PMR who later developed GCA had a risk similar to those initially diagnosed with GCA (aHR 0.85, 95 % CI 0.60-1.19).
Interpretation:
Patients with PMR had a similar risk of large vessel complications compared to the general population and a lower risk compared to those with GCA. These results do not support screening for aortic inflammation among patients with PMR who lack features of GCA.
Insights
Patients with polymyalgia rheumatica (PMR) have a similar risk of aortic complications as the general population. The risk is lower compared to giant cell arteritis (GCA), suggesting no need for routine aortic screening in PMR patients without GCA features.
Area of Science:
- Rheumatology
- Vascular Medicine
- Epidemiology
Background:
- Polymyalgia rheumatica (PMR) may involve subclinical large vessel vasculitis.
- Comparing aortic complication incidence in PMR and giant cell arteritis (GCA) to the general population is crucial for understanding disease associations.
Purpose of the Study:
- To investigate and compare the incidence of aortic complications (aneurysm, dissection/rupture) in patients with PMR and GCA against a matched general population cohort.
- To determine if PMR patients require screening for aortic inflammation.
Main Methods:
- Retrospective cohort study using the TriNetX database (2000-2024) with PMR and GCA patients identified by diagnostic codes and corticosteroid use.
- Matched general population controls (1:3 ratio) were included.
- Cox proportional cause-specific hazard models calculated adjusted hazard ratios (aHR) with PMR as the referent.
Main Results:
- Incidence rates per 1,000 person-years: GCA (11.69), PMR (6.78), general population (5.09).
- GCA patients had a significantly higher risk of aortic complications compared to PMR patients (aHR 1.87).
- PMR patients showed a similar risk to the general population (aHR 0.95).
Conclusions:
- PMR patients exhibit a similar risk of large vessel complications as the general population.
- The risk of aortic complications is lower in PMR than in GCA.
- Routine screening for aortic inflammation is not supported for PMR patients without GCA features.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care

